Under construction – not a live service
Sign in
Not yet taking people in IndonesiaNo phase

Tests cookies with Gynura procumbens for blood sugar in type 2 diabetes

Tests GlucoBites cookies for blood sugar control in adults with type 2 diabetes.

Plain-language title generated from the registry record
Registry title: GlucoBites Cookies (Gynura Procumbens) for Glycemic Control and Prevention of Diabetic Foot Ulcer Risk in Type 2 Diabetes

Key facts

Where
Bantaeng, IndonesiaSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 20 and 70 years old?

Source: NCT07151833, who can take part

Where in Indonesia

  • Public Health Centre of CampagaloeBantaeng, IndonesiaNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Andina Setyawati
Trial code
NCT07151833
Record updated
3 September 2025
Original description
The goal of this randomized controlled trial is to learn if GlucoBites functional cookies containing Gynura procumbens can help improve blood sugar control and lower the risk of diabetic foot ulcers in adults with type 2 diabetes.Read full original descriptionShow less

Efficacy of GlucoBites Functional Cookies Containing Gynura Procumbens on Glycemic Control, Insulin Resistance, and Prevention of Diabetic Foot Ulcer Risk in Patients With Type 2 Diabetes Mellitus: A Randomized Controlled Trial

The goal of this randomized controlled trial is to learn if GlucoBites functional cookies containing Gynura procumbens can help improve blood sugar control and lower the risk of diabetic foot ulcers in adults with type 2 diabetes.

The main questions are:

* Do GlucoBites cookies lower fasting blood glucose and HbA1c? * Do GlucoBites cookies improve insulin resistance and vascular health? * Can GlucoBites reduce early signs that may lead to diabetic foot ulcers?

Researchers will compare:

* Intervention group: participants will eat 4 GlucoBites cookies every day for 12 weeks. * Control group: participants will continue standard diabetes care without GlucoBites.

Participants will:

* Visit the community health center for blood tests and foot health checks. * Be monitored for blood sugar, insulin resistance, lipid profile, and vascular function. * Be assessed for early risk of diabetic foot ulcer development.

This study will help determine if a functional food innovation can support diabetes care and prevent complications.

Inclusion: Adults aged 20-70 years; Diagnosed with type 2 diabetes mellitus (T2DM) based on ADA criteria; HbA1c ≥ 7%; At risk of diabetic foot ulcer (ABI < 0.9 or early neuropathy signs); Willing to consume study cookies and comply with study protocol; Provided written informed consent.

Exclusion: Presence of active diabetic foot ulcer or severe infection; Known allergy to ingredients in study cookies; Severe cardiovascular, renal (eGFR < 30 mL/min/1.73 m²), or hepatic impairment; Current use of herbal supplements or functional foods containing Gynura procumbens; Pregnancy or breastfeeding; Participation in another clinical trial within the last 3 months.

ClinicalTrials.gov NCT07151833